| Macrophage infiltration into adipose tissue: initiation, propagation and remodeling | 2008/01/01 | English | 190 |
| Long-Chain Acyl-Coa Synthetases And Fatty Acid Channeling | 2007/08/01 | English | 187 |
| Role Of Lipids In Brain Injury And Diseases | 2007/08/01 | English | 179 |
| Triacylglycerol Metabolism In Adipose Tissue | 2007/04/01 | English | 118 |
| Apolipoprotein E and cholesterol in aging and disease in the brain | 2008/01/01 | English | 104 |
| Oxidized LDL and the metabolic syndrome | 2008/12/01 | English | 80 |
| Prominin–1 (CD133): from progenitor cells to human diseases | 2006/04/01 | English | 52 |
| Ceramide signaling in cancer and stem cells | 2008/06/01 | English | 50 |
| Adiposopathy: why do adiposity and obesity cause metabolic disease? | 2006/08/01 | English | 50 |
| Role of stearoyl-CoA desaturase in human metabolic disease | 2008/04/01 | English | 28 |
| Fasting-induced adipose factor/angiopoietin–like protein 4: a potential target for dyslipidemia? | 2006/04/01 | English | 26 |
| Targeted bioavailability of drugs by triggered release from liposomes | 2006/02/01 | English | 25 |
| Soy protein, soybean isoflavones and coronary heart disease risk: Where do we stand? | 2007/02/01 | English | 24 |
| Risk of metabolic and vascular disease in South Asians: potential mechanisms for increased insulin resistance | 2008/08/01 | English | 19 |
| Phospholipase A1: structure, distribution and function | 2006/12/01 | English | 18 |
| Structure and function of the enigmatic Sec14 domain-containing proteins and theetiology of human disease | 2008/08/01 | English | 16 |
| Effect of niacin on lipoproteins and atherosclerosis | 2006/10/01 | English | 16 |
| Effects of exercise on postprandial lipoprotein metabolism | 2006/12/01 | English | 15 |
| Roles of eicosanoids in prostate cancer | 2008/08/01 | English | 15 |
| Augmentation Of The Renin–Angiotensin System By Hyper Cholesterolemia Promotes Vascular Diseases | 2008/12/01 | English | 14 |
| Role of lipoprotein lipase in triglyceride metabolism: potential therapeutic target | 2008/08/01 | English | 14 |
| Cholesterol-Lowering Drugs And Alzheimer’S Disease | 2007/08/01 | English | 14 |
| Pathways for phosphatidylcholine biosynthesis: targets and strategies for antimalarial drugs | 2006/04/01 | English | 14 |
| Adipokines and the signaling role of adipose tissue in inflammation and obesity | 2006/02/01 | English | 14 |
| Sphingosine-1-phosphate synthesis and functions in mast cells | 2008/12/01 | English | 13 |
| Nutritional And Nutraceutical Considerations For Dyslipidemia | 2007/06/01 | English | 13 |
| Lipid metabolism in Alzheimer’s and Parkinson’s disease | 2006/08/01 | English | 13 |
| Colesevelam hydrochloride: a specifically engineered bile acid sequestrant | 2008/06/01 | English | 12 |
| Insulin resistance and lipid disorders | 2008/12/01 | English | 12 |
| Torcetrapib And Atherosclerosis: What Happened And Where Do We Go From Here? | 2007/06/01 | English | 11 |